Detection and control of aspartimide formation in the synthesis of cyclic peptides
Authors:
- Huaping MoHMHuaping Mo
- John P. MayerJMJohn P. Mayer
- M. Amin KhanMKM. Amin Khan
- Liang Z. YanLYLiang Z. Yan
- 1 February 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (4) , 1065-1068
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The aspartimide problem in Fmoc‐based SPPS. Part IIJournal of Peptide Science, 2003
- MT‐II Induces Penile Erection via Brain and Spinal MechanismsAnnals of the New York Academy of Sciences, 2003
- The aspartimide problem in Fmoc‐based SPPS. Part IJournal of Peptide Science, 2003
- Current Synthetic Approaches to Peptide and Peptidomimetic CyclizationCurrent Organic Chemistry, 2002
- Chronic Application of MTII in a Rat Model of Obesity Results in Sustained Weight LossObesity Research, 2002
- Preparation of ‘side‐chain‐to‐side‐chain’ cyclic peptides by Allyl and Alloc strategy: potential for library synthesisChemical Biology & Drug Design, 2001
- The synthesis of cyclic peptidesJournal of the Chemical Society, Perkin Transactions 1, 2001
- Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical studyLife Sciences, 1996
- Potent and prolonged-acting cyclic lactam analogs of .alpha.-melanotropin: design based on molecular dynamicsJournal of Medicinal Chemistry, 1989
- Design of a new class of superpotent cyclic .alpha.-melanotropins based on quenched dynamic simulationsJournal of the American Chemical Society, 1989